Monday, November 5, 2007 - 8:35 AM
45a
The Quality by Design Approach to Pharmaceutical Development and Manufacturing
Christine M.V. Moore
, FDA/CDER/ONDQA, Food and Drug Administration, W022 RM2418, 10903 New Hampshire Ave., Silver Spring, MD 20993
Abstract not yet available as of July 15.
See more of
#45 - Quality by Design and Risk Management Plenary Session (TI022)
See more of
Topical I: Pharmaceutical Engineering for the 21Century
See more of
The 2007 Annual Meeting